miRNA-483–5p Targets HDCA4 to Regulate Renal Tubular Damage
                    in Diabetic Nephropathy

Lu Liu; Huanzhen Chen; Jie Yun; Liqun Song; Xiaopeng Ma; Shan Luo; Yexu Song

doi:10.1055/a-1480-7519

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2021; 53(08): 562-569
DOI: 10.1055/a-1480-7519

Endocrine Research

miRNA-483–5p Targets HDCA4 to Regulate Renal Tubular Damage in Diabetic Nephropathy

Lu Liu‡

¹Department of Endocrinology, Seventh People’s Hospital of Shanghai University of TCM, 200137, Shanghai, China

,

Huanzhen Chen‡

²Department of Endocrinology, Putuo People’s Hospital, Tongji University, Shanghai, 200060, China

,

Jie Yun

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Liqun Song

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Xiaopeng Ma

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Shan Luo

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Yexu Song

⁴Department of Science and Technology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

› Author Affiliations

Abstract

This study was designed to evaluate the diagnostic value of miR-483–5p in diabetic nephropathy (DN), and its effect and mechanism on apoptosis and inflammation of human proximal renal tubular cells (HK2) induced by high glucose (HG). Thirty healthy controls, 30 types 2 diabetes mellitus (T2DM) patients, and 28 DN patients were enrolled. miR-483–5p mRNA levels in serum were analyzed by RT-qPCR assays. The receiver operating characteristic curve (ROC) was used to analyze the diagnostic value of miR-483–5p in DN. HK2 cells were induced by HG to establish an in vitro study model. CCK-8 and flow cytometry was used to detect cell viability, apoptosis, and reactive oxygen species (ROS) generation. Inflammation levels were measured by ELISA. Luciferase reporter assay was used to detect target genes of miR-483–5p. miR-483–5p was decreased in DN patients. The decreased level of miR-483–5p was positively correlated with estimated glomerular filtration rate (eGFR) and negatively correlated with proteinuria. miR-483–5p can significantly distinguish DN patients from healthy controls and T2DM and has a high diagnostic value. miR-483–5p decreased in HK2 cells induced by HG, and overexpression of miR-483–5p reversed HG-induced decreased cell activity, increased apoptosis, ROS production, and inflammation. Histone deacetylase 4 (HDCA4) was markedly increased in DN patients and HG-induced HK2 cells. miR-483–5p directly targeted HDCA4, and increasing miR-483–5p inhibited HDCA4 increased in HG-induced HK2. In conclusion, the results indicate that reduction of miR-483–5p has a high diagnostic value in DN, and overexpression of miR-483–5p has a certain protective effect on HK2 cells induced by HG by targeting HDCA4.

Key words

miR-483–5p - diabetic nephropathy - diagnosis

Full Text

References

References
1 Wang Y, Zheng ZJ, Jia YJ. et al. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease. J Transl Med 2018; 16: 146
2 Liu S, Ye L, Tao J. et al. Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2/TACE signalling pathway activity in rats. Pharm Biol 2017; 56: 1-11
3 Dalla Vestra M, Saller A, Bortoloso E. et al. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 2000; 26: 8-14
4 Zhao Y, Chen SJ, Wang JC. et al. Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-kappaB-dependent mechanism. Oxid Med Cell Longev 2015; 934058
5 Jiang X, Ruan XL, Xue YX. et al. Metformin reduces the senescence of renal tubular epithelial cells in diabetic nephropathy via the MBNL1/miR-130a-3p/STAT3 Pathway. Oxid Med Cell Longev. 2020 8708236.
6 Kimura T, Takabatake Y, Takahashi A. et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 2011; 22: 902-913
7 Tramonti G, Kanwar YS. Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy. Endocrine 2013; 43: 494-503
8 Qi SS, Zheng HX, Jiang H. et al. Protective effects of chromium picolinate against diabetic-induced renal dysfunction and renal fibrosis in streptozotocin-induced diabetic rats. Biomolecules 2020; 10: 398
9 Sun Z, Ma Y, Chen F. et al. miR-133b and miR-199b knockdown attenuate TGF-beta1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Eur J Pharmacol 2018; 837: 96-104
10 Wang J, Zhao SM. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy. Life Sci 2021; 264: 118728
11 Luu HN, Lin HY, Sorensen KD. et al. miRNAs associated with prostate cancer risk and progression. BMC Urol 2017; 17: 18
12 Hong Y, Wang J, Zhang L. et al. Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy. Ann Clin Biochem 2021; 58: 141-148
13 Wang J, Duan L, Tian L. et al. Serum miR-21 may be a potential diagnostic biomarker for diabetic nephropathy. Exp Clin Endocrinol Diabetes 2016; 124: 417-423
14 Rovira-Llopis S, Escribano-Lopez I, Diaz-Morales N. et al. Downregulation of miR-31 in diabetic nephropathy and its relationship with inflammation. Cell Physiol Biochem 2018; 50: 1005-1014
15 Su J, Ren J, Chen H. et al. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-kappaB signaling pathway in human renal tubular epithelial cells. Biosci Rep 2020; 40 BSR20192384
16 Cui K, Zhang H, Wang GZ. MiR-483 suppresses cell proliferation and promotes cell apoptosis by targeting SOX3 in breast cancer. Eur Rev Med Pharmacol Sci 2019; 23: 2069-2074
17 Tian Y, Yan M, Zheng J. et al. miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1. Lab Invest 2019; 99: 602-611
18 Li L, Li S, Wu M. et al. Early diagnostic value of circulating microRNAs in patients with suspected acute myocardial infarction. J Cell Physiol 2019; 234: 13649-13658
19 Chouri E, Servaas NH, Bekker CPJ. et al. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. J Autoimmun 2018; 89: 162-170
20 Wang XG, Zhu YW, Wang T. et al. MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma. Kaohsiung J Med Sci 2020; 37: 192-199
21 Gallo W, Esguerra JLS, Eliasson L. et al. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease. PLoS One 2018; 13: e0206974
22 Zhang YH, Zhang YQ, Guo CC. et al. Prostaglandin E1 attenuates high glucose-induced apoptosis in proximal renal tubular cells by inhibiting the JNK/Bim pathway. Acta Pharmacol Sin 2020; 41: 561-571
23 Zhang YL, Wang JM, Yin H. et al. DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose. Ren Fail 2020; 42: 463-473
24 He M, Wang J, Yin Z. et al. MiR-320a induces diabetic nephropathy via inhibiting MafB. Aging (Albany NY) 2019; 11: 3055-3079
25 Sun F, Yu PF, Wang D. et al. MicroRNA-488 regulates diabetic nephropathy via TGF-beta1 pathway. Eur Rev Med Pharmacol Sci 2019; 23: 4333-4340
26 Xie C, Wu W, Tang A. et al. lncRNA GAS5/miR-452-5p Reduces Oxidative Stress and Pyroptosis of High-Glucose-Stimulated Renal Tubular Cells. Diabetes Metab Syndr Obes 2019; 12: 2609-2617
27 El-Samahy MH, Adly AA, Elhenawy YI. et al. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. J Diabetes Complications 2018; 32: 185-192
28 Fouad M, Salem I, Elhefnawy K. et al. MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes. Indian J Nephrol 2020; 30: 21-25
29 Shen Z, Tang W, Guo J. et al. miR-483-5p plays a protective role in chronic obstructive pulmonary disease. Int J Mol Med 2017; 40: 193-200
30 Chen SJ, Wu P, Sun LJ. et al. miR-204 regulates epithelial-mesenchymal transition by targeting SP1 in the tubular epithelial cells after acute kidney injury induced by ischemia-reperfusion. Oncol Rep 2017; 37: 1148-1158
31 Kim Y, Park CW. New therapeutic agents in diabetic nephropathy. Korean J Intern Med 2017; 32: 11-25
32 Ivory SE, Packham DK, Reutens AT. et al. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers. Nephrology (Carlton) 2013; 18: 516-524
33 Oreglia M, Sbiera S, Fassnacht M. et al. Early postoperative circulating miR-483-5p is a prognosis marker for adrenocortical cancer. Cancers. Basel; 2020. 12. 724
34 Cheng J, Yang A, Cheng S. et al. Circulating miR-19a-3p and miR-483-5p as novel diagnostic biomarkers for the early diagnosis of gastric cancer. Med Sci Monit 2020; 26: e923444
35 Yang L, Shao J, Bian Y. et al. Prevalence of type 2 diabetes mellitus among inland residents in China (2000-2014): A meta-analysis. J Diabetes Investig 2016; 7: 845-852
36 Wang H, Zhang H, Sun Q. et al. Chondrocyte mTORC1 activation stimulates miR-483-5p via HDAC4 in osteoarthritis progression. J Cell Physiol 2019; 234: 2730-2740
37 Luo L, Martin SC, Parkington J. et al. HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1alpha, and Hsc70. Cell Rep 2019; 29: e712
38 Wang X, Liu J, Zhen J. et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int 2014; 86: 712-725
39 Gondaliya P, A PD Jash K. et al. miR-29b attenuates histone deacetylase-4 mediated podocyte dysfunction and renal fibrosis in diabetic nephropathy. J Diabetes Metab Disord 2020; 19: 13-27